Title : Rosiglitazone monotherapy improves glycaemic control in patients with type 2 diabetes: a twelve-week, randomized, placebo-controlled study.

Pub. Date : 1999 May

PMID : 11220295






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 AIM: Rosiglitazone is the most potent of the thiazolidinediones, a novel class of oral antidiabetic agents that reduce blood glucose levels by sensitizing peripheral tissues to insulin. Rosiglitazone insulin Homo sapiens